Company news

SAB Biotherapeutics, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

SAB Biotherapeutics Announces SAB-185 Retains Neutralization Against Omicron SARS-CoV-2 Variant In Vitro

December 15, 2021

SAB Biotherapeutics Announces SAB-176 Met its Primary Endpoint in Phase 2a Challenge Study in Adults Infected with Influenza Virus

November 30, 2021

SAB Biotherapeutics Reports Third Quarter 2021 Financial Results and Provides Company Update

November 21, 2021

SAB Biotherapeutics Debuts as Publicly Traded Next-Generation Immunotherapy Company

October 24, 2021

SAB Biotherapeutics to Host Virtual R&D Day on October 13, 2021

October 5, 2021

SAB Biotherapeutics Announces First Patient Dosed in Phase 3 NIH ACTIV-2 Trial Evaluating SAB-185 for Treatment of COVID-19

October 3, 2021

SAB Biotherapeutics Appoints Russell Beyer Chief Financial Officer

September 27, 2021

SAB Biotherapeutics Announces SAB-185 Receives Positive DSMB Review and Advances to Phase 3 in NIH-Sponsored ACTIV-2 Trial for Treatment of COVID-19

September 23, 2021

SAB Biotherapeutics Awarded Additional $60.5M from BARDA and U.S. Department of Defense for Rapid Response Capability and Advancing SAB-185 for Treatment of COVID-19

September 21, 2021

SAB Biotherapeutics Announces Completion of Enrollment in Phase 2a Challenge Trial of SAB-176 for the Treatment of Seasonal Influenza

September 14, 2021

SAB Biotherapeutics Announces Nonclinical Data Demonstrating SAB-185 Potently Neutralizes Delta and Lambda SARS-CoV-2 Variants

August 10, 2021

SAB Biotherapeutics Announces Publication of Preclinical Data Demonstrating SAB-185 Effectively Neutralizes SARS-CoV-2 Variants

July 7, 2021

SAB Biotherapeutics to List on Nasdaq through Merger with Big Cypress Acquisition Corp., Advancing Unique Human Antibody Platform with Demonstrated Utility in Immunotherapy and Rapid Response to Emerging Diseases

June 21, 2021

← Newer news releases

Calls

Decks

The 5 newest of 19 decks. Every deck is listed under its year.